Edgestream Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
47,631
-10,765
| -18% | -$61.7K | 0.01% | 793 |
|
|
2025
Q1 | $477K | Buy |
+58,396
| New | +$477K | 0.02% | 705 |
|
|
2024
Q4 | – | Sell |
-258,605
| Closed | -$2.76M | – | 935 |
|
|
2024
Q3 | $2.76M | Buy |
258,605
+167,735
| +185% | +$1.79M | 0.12% | 306 |
|
|
2024
Q2 | $901K | Sell |
90,870
-179,294
| -66% | -$1.78M | 0.04% | 546 |
|
|
2024
Q1 | $3.18M | Buy |
270,164
+250,734
| +1,290% | +$2.95M | 0.16% | 216 |
|
|
2023
Q4 | $276K | Sell |
19,430
-85,967
| -82% | -$1.22M | 0.02% | 737 |
|
|
2023
Q3 | $1.28M | Sell |
105,397
-159,938
| -60% | -$1.94M | 0.1% | 319 |
|
|
2023
Q2 | $3.33M | Buy |
+265,335
| New | +$3.33M | 0.3% | 60 |
|